Yoon, Y.; Cho, H.-K.; Kim, K.H.; Park, S.E.; Kim, Y.-J.; Lee, J.; Kim, H.M.; Kim, N.H.; Jo, D.S.; Cho, E.Y.;
et al. Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6–35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial. Vaccines 2026, 14, 341.
https://doi.org/10.3390/vaccines14040341
AMA Style
Yoon Y, Cho H-K, Kim KH, Park SE, Kim Y-J, Lee J, Kim HM, Kim NH, Jo DS, Cho EY,
et al. Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6–35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial. Vaccines. 2026; 14(4):341.
https://doi.org/10.3390/vaccines14040341
Chicago/Turabian Style
Yoon, Yoonsun, Hye-Kyung Cho, Ki Hwan Kim, Su Eun Park, Yae-Jean Kim, Jina Lee, Hwang Min Kim, Nam Hee Kim, Dae Sun Jo, Eun Young Cho,
and et al. 2026. "Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6–35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial" Vaccines 14, no. 4: 341.
https://doi.org/10.3390/vaccines14040341
APA Style
Yoon, Y., Cho, H.-K., Kim, K. H., Park, S. E., Kim, Y.-J., Lee, J., Kim, H. M., Kim, N. H., Jo, D. S., Cho, E. Y., Shin, S. H., Kim, J.-H., Ryu, J. H., Park, H. K., Lee, Y., & Kim, Y.-K.
(2026). Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6–35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial. Vaccines, 14(4), 341.
https://doi.org/10.3390/vaccines14040341
